ERBB2 and cancer: Then, we prove the multiplexing technique can be applied to a biosensing application, employing four sensors with two different biofunctionalizations for the simultaneous detection of two cancer biomarkers, namely CD44 [30] and HER2 [23], which are both employed in the diagnostics of breast cancer diseases [27,31].